Rafferty Asset Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-3,910
Closed -$970K – 1097
2025
Q4
$970K Buy
+3,910
New +$893K ﹤0.01% 805
2023
Q1
– Sell
-34,644
Closed -$6.01M – 1154
2022
Q4
$6.01M Buy
34,644
+31,776
+1,108% +$20.9M 0.05% 340
2022
Q3
$2.75M Buy
2,868
+1,046
+57% +$1.04M 0.03% 439
2022
Q2
$1.22M Sell
1,822
-559
-23% -$347K 0.01% 586
2022
Q1
$1.65M Buy
2,381
+83
+4% +$64K 0.01% 668
2021
Q4
$2.08M Buy
2,298
+1,326
+136% +$1.26M 0.01% 646
2021
Q3
$977K Sell
972
-439
-31% -$323K 0.01% 835
2021
Q2
$916K Sell
1,411
-759
-35% -$526K 0.01% 947
2021
Q1
$1.61M Buy
2,170
+1,857
+593% +$1.5M 0.01% 680
2020
Q4
$242K Sell
313
-285
-48% -$225K ﹤0.01% 923
2020
Q3
$594K Buy
598
+388
+185% +$412K 0.01% 667
2020
Q2
$218K Buy
+210
New +$211K ﹤0.01% 909
2020
Q1
– Sell
-534
Closed -$668K – 688
2019
Q4
$668K Buy
+534
New +$860K 0.01% 638

Other funds holding GOSS

Rafferty Asset Management's GOSS Position: Q1 2026 in Review

Rafferty Asset Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 3,910 shares — an estimated $970K sold.

Rafferty Asset Management first reported a position in GOSS in Q4 2019 and held it in 13 quarters. The position peaked at $6.01M in Q4 2022. 181 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Rafferty Asset Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Rafferty Asset Management sold 3,910 Gossamer Bio shares in Q1 2026, an estimated $970K.
  • Rafferty Asset Management first reported a position in Gossamer Bio in Q4 2019 and held it in 13 quarters.
  • Rafferty Asset Management's Gossamer Bio position peaked at $6.01M in Q4 2022.
  • 181 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.